The company has completed tens of millions of RMB A+ round financing, which was jointly invested by Suzhou Gaozhan Investment and Kunshan Hi-tech Venture Capital. With the strong support of the government and investors, the company will focus on cancer operation, further accelerate the R&D and industrialization of innovative appliances and drug devices combined with innovative drug delivery agents.